TrialOncotarget2017

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma.

Yago Pico de Coaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.